SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Biotech Jim who wrote (1817)11/4/2015 8:54:19 AM
From: Biotech Jim  Respond to of 3559
 
What is FOP?

What is Fibrodysplasia Ossificans Progressiva (FOP)?
One of the rarest, most disabling genetic conditions known to medicine, it causes bone to form in muscles, tendons, ligaments and other connective tissues. Bridges of extra bone develop across joints, progressively restricting movement and forming a second skeleton that imprisons the body in bone. There are no other known examples in medicine of one normal organ system turning into another.

ifopa.org

Penn Researchers Discover Gene That Creates Second Skeleton
Pinpointing Cause of Fibrodysplasia Ossificans Progressiva (FOP) Will Accelerate Development of Treatments for FOP and Common Bone Disorders
uphs.upenn.edu



To: Biotech Jim who wrote (1817)11/4/2015 9:44:17 AM
From: Miljenko Zuanic  Respond to of 3559
 
Dupilumab BLA should be at FDA by mid-16 and approved by early-17.